Cornelis H van Werkhoven Selected Research

Anti-Bacterial Agents (Antibiotics)

1/2022	Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial.
12/2021	An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
7/2021	Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.
1/2021	Microbiota-based markers predictive of development of Clostridioides difficile infection.
1/2021	Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.
1/2021	Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: authors' response.
11/2019	Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis.
10/2017	Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
1/2017	Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines.
4/2015	Antibiotic treatment strategies for community-acquired pneumonia in adults.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelis H van Werkhoven Research Topics

Disease

18	Pneumonia (Pneumonitis) 01/2022 - 01/2015
8	Pneumococcal Infections 12/2018 - 01/2015
5	COVID-19 03/2024 - 01/2022
4	Infections 01/2022 - 03/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 09/2022 - 01/2021
2	Sepsis (Septicemia) 10/2023 - 12/2021
2	Human Influenza (Influenza) 08/2023 - 01/2022
2	Urinary Tract Infections (Urinary Tract Infection) 03/2022 - 01/2022
2	Clostridium Infections 01/2021 - 01/2021
2	Pneumococcal Pneumonia 01/2016 - 03/2015
1	Communicable Diseases (Infectious Diseases) 03/2024
1	Surgical Wound Infection 10/2023
1	Bacteremia 01/2023
1	Diabetes Complications 03/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Q Fever (Fever, Q) 09/2021
1	Diarrhea 01/2021
1	Dysbiosis 01/2021
1	Pyelonephritis 11/2019
1	Cystitis 11/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Heart Failure 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Diabetes Mellitus 01/2017
1	Tachypnea 01/2015
1	Hypotension (Low Blood Pressure) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Tachycardia (Tachyarrhythmias) 01/2015
1	Pain (Aches) 01/2015
1	Leukopenia 01/2015
1	Leukocytosis (Pleocytosis) 01/2015

Drug/Important Bio-Agent (IBA)

12	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2015
9	VaccinesIBA 08/2023 - 01/2015
9	Conjugate VaccinesIBA 07/2021 - 01/2015
3	beta-LactamsIBA 01/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 11/2023 - 09/2021
2	BCG Vaccine FDA Link 09/2022 - 01/2022
2	Nitrofurantoin (Macrodantin)FDA LinkGeneric 03/2022 - 11/2019
2	Polysaccharides (Glycans)IBA 12/2018 - 03/2015
2	protein C activator peptideIBA 01/2016 - 01/2015
1	Complement System Proteins (Complement)IBA 03/2024
1	COVID-19 VaccinesIBA 11/2023
1	IgG Receptors (Fc gamma RI)IBA 11/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Insulin (Novolin)FDA Link 03/2022
1	Fosfomycin FDA Link 01/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Third Generation CephalosporinsIBA 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2019
1	Erythromycin (Erycette)FDA LinkGeneric 01/2019
1	MacrolidesIBA 01/2019
1	FluoroquinolonesIBA 01/2019
1	Moxifloxacin (Avelox)FDA Link 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	AntigensIBA 03/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	C-Reactive ProteinIBA 01/2015
1	SodiumIBA 01/2015

Therapy/Procedure

3	Therapeutics 09/2021 - 01/2017
1	Operative Surgical Procedures 10/2023